On December 19, 2024, Herbs Generation Group Holdings Limited (2593.HK, Herbs Group), successfully listed on the Main Board of the Hong Kong Stock Exchange (HKEx). The total fund raising size of this IPO was approximately HKD125 million. The market responded positively and the public offering was oversubscribed for more than 6,000 times, recording the 2nd highest in Hong Kong market. CBI is honored to participate in the due diligence work for this IPO Project.
Herbs Group is a provider of a variety of health supplements and cosmetics and skincare products in Hong Kong established for over 20 years. The company focuses on the development, sales and marketing of products under our own brands. It carried a total of eight own brands, including Herbs, ZINO and Classic, etc, and had 33 self-operated stores and two brand experience centres across different districts in Hong Kong.
In this IPO project, CBI primarily assisted the sponsor team in conducting due diligence on the group company, its directors, senior management, shareholders, suppliers and customers. In addition to the basic information such as litigation, bankruptcy, winding-up and media records, CBI also assisted the sponsor team in conducting Reference Check and Reputation Intelligence. The due diligence project globally covers 7 countries and regions, including China, Hong Kong, Taiwan and Canada, etc.